Praveen P. Tipirneni - Apr 25, 2023 Form 4 Insider Report for Morphic Holding, Inc. (MORF)

Role
President and CEO, Director
Signature
/s/ Robert Farrell as attorney-in-fact for Praveen P. Tipirneni
Stock symbol
MORF
Transactions as of
Apr 25, 2023
Transactions value $
-$1,235,894
Form type
4
Date filed
4/27/2023, 07:04 PM
Previous filing
Jan 18, 2023
Next filing
May 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MORF Common Stock Options Exercise $109K +25.2K +180.68% $4.32* 39.1K Apr 25, 2023 Direct F1
transaction MORF Common Stock Sale -$1.34M -25.2K -64.37% $53.40 13.9K Apr 25, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MORF Stock Option (right to buy Common Stock) Options Exercise $0 -25.2K -6.27% $0.00 376K Apr 25, 2023 Common Stock 25.2K $4.32 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 395 shares of Common Stock acquired on February 28, 2022, and 862 shares of Common Stock acquired on February 28, 2023 under the Issuer's employee stock purchase plan.
F2 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder dated September 16, 2022.
F3 This option is fully vested.